2. 脂質
  3. Isotope-Labeled Lipids
  4. Isotope-Labeled Fatty Esters
  5. Isotope-Labeled Fatty Acyl Carnitines

Isotope-Labeled Fatty Acyl Carnitines

Isotope-Labeled Fatty Acyl Carnitines (14):

製品番号 製品名 CAS 番号 純度 構造式
  • HY-113147AS
    L-Palmitoylcarnitine-d3 hydrochloride 1334532-26-1 99.94%
    L-Palmitoylcarnitine-d3 hydrochloride is the deuterium labeled L-Palmitoylcarnitine hydrochloride. L-Palmitoylcarnitine hydrochloride, a long-chain acylcarnitine and a fatty acid metabolite, accumulates in the sarcolemma and deranges the membrane lipid environment during ischaemia. L-Palmitoylcarnitine hydrochloride inhibits KATP channel activity, without affecting the single channel conductance, through interaction with Kir6.2.
    L-Palmitoylcarnitine-d<sub>3</sub> hydrochloride
  • HY-113161S1
    L-Octanoylcarnitine-d9 2847775-88-4
    L-Octanoylcarnitine-d9 is deuterium labeled L-Octanoylcarnitine. L-Octanoylcarnitine is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine can be used for the research of breast cancer.
    .
    L-Octanoylcarnitine-d<sub>9</sub>
  • HY-113261S
    Oleoylcarnitine-d9 2847775-85-1 99.0%
    Oleoylcarnitine-d9 is deuterium labeled Oleoylcarnitine. Oleoylcarnitine, the metabolite which accumulates through suppression of fatty acid β-oxidation, can enhance hepatocarcinogenesis via STAT3 activation.
    Oleoylcarnitine-d<sub>9</sub>
  • HY-113201S
    Tetradecanoylcarnitine-d9 2245713-18-0
    Tetradecanoylcarnitine-d9 is deuterium labeled Tetradecanoylcarnitine. Tetradecanoylcarnitine is a human carnitine involved in β-oxidation of long-chain fatty acids.
    Tetradecanoylcarnitine-d<sub>9</sub>
  • HY-113144S
    L-Hexanoylcarnitine-d9 2847775-84-0
    L-Hexanoylcarnitine-d9 is deuterium labeled L-Hexanoylcarnitine. L-Hexanoylcarnitine is an acylcarnitine and also a urinary biomarker for hyperlipidemia. The expression of L-Hexanoylcarnitine is upregulated in colorectal cancer cells, which is associated with metabolic pathways related to cell growth and proliferation. L-Hexanoylcarnitine can be used in studies related to hyperlipidemia and stage B colorectal cancer.
    L-Hexanoylcarnitine-d<sub>9</sub>
  • HY-113161S
    L-Octanoylcarnitine-d3 204259-56-3
    L-Octanoylcarnitine-d3 is the deuterium-labeled L-Octanoylcarnitine (HY-113161). L-Octanoylcarnitine-d3 is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine-d3 can be used for the research of breast cancer.
    L-Octanoylcarnitine-d<sub>3</sub>
  • HY-152004S
    Acetyl-L-carnitine-d3-2 hydrochloride 2692623-93-9
    Acetyl-L-carnitine-d3-2 (hydrochloride) is a deuterated Acetyl-L-carnitine. Acetyl-L-carnitine is an orally active mitochondrial energy metabolism regulator and neuroprotectant that can penetrate the blood-brain barrier.
    Acetyl-L-carnitine-d<sub>3</sub>-2 hydrochloride
  • HY-126358S
    Acetylcarnitine-d3 204259-54-1
    Acetylcarnitine-d3 is the deuterium labeled Acetylcarnitine (HY-126358). Acetylcarnitine is an endogenous metabolite.
    Acetylcarnitine-d<sub>3</sub>
  • HY-170001S
    Palmitoyl-L-carnitine-d9 chloride
    Palmitoyl-L-carnitine-d9 (chloride) is deuterium labeled Palmitoyl-L-carnitine (chloride).
    Palmitoyl-L-carnitine-d<sub>9</sub> chloride
  • HY-113218S
    Acetyl-L-carnitine-d9 203805-90-7
    Acetyl-L-carnitine-d9 (O-Acetyl-L-carnitine-d9) is deuterium labeled Acetyl-L-carnitine. Acetyl-L-carnitine (O-Acetyl-L-carnitine) is a compound involved in human metabolic research. It has relevant applications in predicting metabolite biomarker changes using the Recon 2 metabolic reconstruction model and integrating and analyzing multiple data types, but its specific activity mechanism is not described in detail based on the existing information.
    Acetyl-L-carnitine-d<sub>9</sub>
  • HY-113147S1
    L-Palmitoylcarnitine-d9 2847775-90-8 99.0%
    L-Palmitoylcarnitine-d9 is deuterium labeled L-Palmitoylcarnitine. L-Palmitoylcarnitine, a long-chain acylcarnitine and a fatty acid metabolite, accumulates in the sarcolemma and deranges the membrane lipid environment during ischaemia. L-Palmitoylcarnitine inhibits KATP channel activity, without affecting the single channel conductance, through interaction with Kir6.2.
    L-Palmitoylcarnitine-d<sub>9</sub>
  • HY-113168AS
    (±)-Butyrylcarnitine-d9 2936622-23-8
    (±)-Butyrylcarnitine-d9 is deuterium labeled (±)-Butyrylcarnitine.
    (±)-Butyrylcarnitine-d<sub>9</sub>
  • HY-113202S1
    Stearoyl-L-carnitine-d9 chloride 2936622-19-2
    Stearoyl-L-carnitine-d9 chloride is the deuterium labeled Stearoyl-L-carnitine chloride. Stearoyl-L-carnitine chloride, a fatty ester lipid molecule, is an endogenous metabolite. Stearoyl-L-carnitine chloride can be used as PKC inhibitor. Stearoyl-L-carnitine chloride accumulates in β cells, leading to arrest of insulin synthesis and energy deficiency in type 2 diabetes mouse. Stearoyl-L-carnitine chloride inhibits lecithin cholesterol acyltransferase (LCAT) in rat and rabbits plasma. Stearoyl-L-carnitine chloride acts as a metabolomics biomarker for Parkinson’s disease. Stearoyl-L-carnitine chloride is a less potent inhibitor of GlyT2.
    Stearoyl-L-carnitine-d<sub>9</sub> chloride
  • HY-113202S
    Stearoyl-L-carnitine-d3 1021439-31-5
    Stearoyl-L-carnitine-d3 is the deuterium labeled Stearoylcarnitine. Stearoylcarnitine, a fatty ester lipid molecule, is an endogenous metabolite. Stearoylcarnitine can be used as PKC inhibitor. Stearoylcarnitine accumulates in β cells, leading to arrest of insulin synthesis and energy deficiency in type 2 diabetes mouse. Stearoylcarnitine inhibits lecithin cholesterol acyltransferase (LCAT) in rat and rabbits plasma. Stearoylcarnitine acts as a metabolomics biomarker for Parkinson’s disease. Stearoylcarnitine is a less potent inhibitor of GlyT2.
    Stearoyl-L-carnitine-d<sub>3</sub>